Fitness fans often turn to eggs as a food staple, but there is one other 'superfood' that contains more protein per gram and ...

On Dec 12, 2024, the US Food and Drug Administration (FDA) approved crinecerfont for adults and paediatric patients with ...

Detailed price information for Profound Medical Corp (PROF-Q) from The Globe and Mail including charting and trades.

Allegheny Health Network announced it is the first health care system in Western Pennsylvania to offer Aquablation therapy ...

Boys and young adult male patients with congenital adrenal hyperplasia receiving glucocorticoid treatment have lower bone ...

ABSTRACT: Background: The prevalence of benign prostatic hyperplasia, BPH is increasing in our environment. Besides androgens and age could there be other risk factors? Aim: To investigate the roles ...

HBM Alpha Therapeutics Inc. signed a potential $395 million licensing deal Feb. 26 with an unnamed “business partner” for its endocrine asset, HAT-001, adding another contender to the congenital ...

Olympus Corporation of Asia Pacific (Olympus APAC) is launching its iTind device for treating benign prostatic hyperplasia ...

The following is a summary of “Surgical outcomes of transurethral enucleation with bipolar energy for benign prostatic hyperplasia: single surgeon’s initial experience,” published in the February 2025 ...

Image credit: Aria sandi hasim via Shutterstock. Olympus Corporation of Asia Pacific (Olympus APAC) is launching its iTind device for treating benign prostatic hyperplasia (BPH) in South Korea. Also ...

“While there are other treatment options available for treating BPH, there remains a significant need for much less invasive treatment approaches that can preserve and protect the integrity of the ...

Based on drug type, the global Benign Prostatic Hyperplasia Surgical Treatment market can be divided into three segments: alpha-blockers (α-blockers), 5-alpha reductase inhibitors (5-ARIs), and ...